Abstract

Curcumin is an active polyphenol substance found in the highest concentrations in the roots of Curcuma longa. Its health benefits have led to recent increases in the consumption of curcumin. It has anti-inflammatory and antioxidant activities and is a potent neuroprotective against diseases of the brain. Nevertheless, its low bioavailability and its relative difficulty crossing the blood-brain barrier limit curcumin’s use for these purposes. Curcumin-loaded nanoparticles may be an effective treatment for several diseases although there is a paucity of studies reporting its safety in the central nervous system (CNS). Therefore, this study aimed to identify non-neurotoxic concentrations of free curcumin and two nanoformulations of curcumin. Cell lines BV-2 and SH-SY5Y, both originating from the CNS, were evaluated after 24, 48, and 72 h of treatment with free curcumin and nanocapsules We measured viability, proliferation, and dsDNA levels. We measured levels of reactive oxygen species and nitric oxide as proxies for oxidative stress in culture supernatants. We found that free curcumin was toxic at 10 and 20 µM, principally at 72 h. Nanoformulations were more neurotoxic than the free form. Safe concentrations of free curcumin are between 1–5 µM, and these concentrations were lower for nanoformulations. We determined the ideal concentrations of free curcumin and nanocapsules serving as a basis for studies of injuries that affect the CNS.

Highlights

  • Natural products are increasingly studied for the treatment of diseases

  • Curcumin treatments decrease or increase viability depending on the exposure time To determine the viability of BV-2 cells against exposure of treatments with free and nanoencapsulated curcumin, the MTT assay demonstrated, that 20 μM of NB-Eudragit L‐100 (EDG) decreased microglial viability at 24 h, as did 0.01 and 20 μM NC-EDG

  • The physio-chemical characteristics of both curcumin nanocapsules showed an efficiency of encapsulation and uniformity of nanometric size; these results were satisfactory according to the production protocol established by our research group [29, 30]

Read more

Summary

Introduction

Curcumin is the primary active compound present in the roots of the Curcuma longa plant This polyphenol has as anti-inflammatory, antioxidant, antimicrobial, and anticarcinogenic properties [1,2,3,4]. In an in vitro experimental model of neurodegenerative disease, Armagan and Naziroglu [11] reported the neuroprotective action of curcumin by modulating oxidative stress. This polyphenol is capable to decrease neurotoxicity, which is proven by other models of neurological disorders in vitro [11,12,13,14,15] and in vivo studies [16, 17]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call